Dysbiosis, or microbial imbalance, is believed to disrupt this axis, leading to alterations in gut motility, pain sensitivity, and immune responses, which are common in conditions like IBS and IBD
NICE approved semaglutide (Wegovy) for weight management in specialist NHS weight management services in 2023 (TA875), but availability is limited to patients with: BMI 35 kg/m with at least one weight-related comorbidity, or BMI 30 kg/m with exceptional circumstances Lower BMI thresholds apply for people from some minority ethnic groups (typically 27.5 kg/m) Participation in a specialist weight management programme Treatment limited to a maximum of 2 years Access varies by region due to local integrated care board (ICB) implementation decisions and limited NHS specialist service capacity
The post hoc Tukey test was also utilised to analyze the differences in variable subgroups
Documented practice is to start a fresh vial after about 4 weeks regardless of remaining volume, or to reconstitute a smaller portion if doses are very low
Hadidchi will work closely with you to develop a personalized treatment plan, which may include Ozempic alongside lifestyle modifications and other supportive therapies
